Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gammon DC et al. - Combination treatment with CS followed by IPHC in 15 patients with heterogeneous primary sources of intraabdominal malignancies resulted in a median survival time of 8.4 months.

Related Articles

KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
Annals of Surgical Oncology, 11/11/09    Relevance Score: 67%

Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection
European Journal of Surgical Oncology, 11/17/09    Relevance Score: 65%

Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT
Abdominal Imaging, 10/01/09    Relevance Score: 65%

Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
The Journal of Nuclear Medicine, 11/16/09    Relevance Score: 64%

Prolonged peritoneal gene expression using a helper-dependent adenovirus
Peritoneal Dialysis International, 10/01/09    Relevance Score: 45%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address